{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:50:56Z","timestamp":1788292256095,"version":"build-2803163510"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001588","name":"Enterprise Ireland","doi-asserted-by":"publisher","award":["CF-2019-1136-P"],"award-info":[{"award-number":["CF-2019-1136-P"]}],"id":[{"id":"10.13039\/501100001588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-023-10371-w","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T06:02:01Z","timestamp":1700805721000},"page":"257-276","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Large animal models to study effectiveness of therapy devices in the treatment of heart failure with preserved ejection fraction (HFpEF)"],"prefix":"10.1007","volume":"29","author":[{"given":"Shane Michael","family":"Fisher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali Rosanna","family":"Murally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Rajabally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talal","family":"Almas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maimoona","family":"Azhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal H.","family":"Cheema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Malone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babar","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemil","family":"Saidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9242-6185","authenticated-orcid":false,"given":"Aamir","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,24]]},"reference":[{"key":"10371_CR1","unstructured":"National Heart LaBI (2021) Cardiovascular disease is on the rise, but we know how to curb it. We\u2019ve done it before. Available from\u00a0https:\/\/www.nhlbi.nih.gov\/news\/2021\/cardiovascular-disease-rise-we-know-how-curb-it-weve-done-it"},{"key":"10371_CR2","unstructured":"Barry A Borlaug WSC (2022) Treatment and prognosis of heart failure with preserved ejection fraction. UpToDate"},{"key":"10371_CR3","doi-asserted-by":"publisher","first-page":"638","DOI":"10.3389\/fphys.2019.00638","volume":"10","author":"AB Gevaert","year":"2019","unstructured":"Gevaert AB, Boen JRA, Segers VF, Van Craenenbroeck EM (2019) Heart failure with preserved ejection fraction: a review of cardiac and noncardiac pathophysiology. Front Physiol 10:638","journal-title":"Front Physiol"},{"issue":"9","key":"10371_CR4","first-page":"582","volume":"96","author":"JD Gazewood","year":"2017","unstructured":"Gazewood JD, Turner PL (2017) Heart failure with preserved ejection fraction: diagnosis and management. Am Fam Physician 96(9):582\u2013588","journal-title":"Am Fam Physician"},{"issue":"4","key":"10371_CR5","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s11897-013-0155-7","volume":"10","author":"AA Oktay","year":"2013","unstructured":"Oktay AA, Rich JD, Shah SJ (2013) The emerging epidemic of heart failure with preserved ejection fraction. Curr Heart Fail Rep 10(4):401\u2013410","journal-title":"Curr Heart Fail Rep"},{"issue":"5","key":"10371_CR6","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.jacc.2019.05.052","volume":"74","author":"J Tromp","year":"2019","unstructured":"Tromp J, Shen L, Jhund PS, Anand IS, Carson PE, Desai AS et al (2019) Age-related characteristics and outcomes of patients with heart failure with preserved ejection fraction. J Am Coll Cardiol 74(5):601\u2013612","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10371_CR7","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.jacc.2020.06.069","volume":"76","author":"M Guazzi","year":"2020","unstructured":"Guazzi M, Ghio S, Adir Y (2020) Pulmonary hypertension in HFpEF and HFrEF: JACC review topic of the week. J Am Coll Cardiol 76(9):1102\u20131111","journal-title":"J Am Coll Cardiol"},{"key":"10371_CR8","unstructured":"Clinic M (2015) Heart failure with preserved ejection fraction (HFpEF): more than diastolic dysfunction. Available from\u00a0https:\/\/www.mayoclinic.org\/medical-professionals\/cardiovascular-diseases\/news\/heart-failure-with-preserved-ejection-fraction-hfpef-more-than-diastolic-dysfunction\/mac-20430055"},{"issue":"2","key":"10371_CR9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1161\/CIRCHEARTFAILURE.113.000823","volume":"7","author":"M Guazzi","year":"2014","unstructured":"Guazzi M (2014) Pulmonary hypertension in heart failure preserved ejection fraction: prevalence, pathophysiology, and clinical perspectives. Circ Heart Fail 7(2):367\u2013377","journal-title":"Circ Heart Fail"},{"issue":"4","key":"10371_CR10","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3390\/medicina57040375","volume":"57","author":"MB Zamfirescu","year":"2021","unstructured":"Zamfirescu MB, Ghilencea LN, Popescu MR, Bejan GC, Maher SM, Popescu AC, Doroban\u021bu M (2021) The E\/e\u2019Ratio\u2014role in risk stratification of acute heart failure with preserved ejection fraction. Medicina 57(4):375","journal-title":"Medicina"},{"issue":"4","key":"10371_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s12471-016-0815-9","volume":"24","author":"G Concei\u00e7\u00e3o","year":"2016","unstructured":"Concei\u00e7\u00e3o G, Heinonen I, Louren\u00e7o AP, Duncker DJ, Falc\u00e3o-Pires I (2016) Animal models of heart failure with preserved ejection fraction. Neth Heart J 24(4):275\u2013286","journal-title":"Neth Heart J"},{"issue":"10","key":"10371_CR12","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.3390\/ani10101906","volume":"10","author":"CJ Charles","year":"2020","unstructured":"Charles CJ, Rademaker MT, Scott NJ, Richards AM (2020) Large animal models of heart failure: reduced vs. preserved ejection fraction. Animals 10(10):1906","journal-title":"Animals"},{"issue":"2","key":"10371_CR13","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10741-021-10184-9","volume":"27","author":"C Miyagi","year":"2022","unstructured":"Miyagi C, Miyamoto T, Kuroda T, Karimov JH, Starling RC, Fukamachi K (2022) Large animal models of heart failure with preserved ejection fraction. Heart Fail Rev 27(2):595\u2013608","journal-title":"Heart Fail Rev"},{"issue":"2","key":"10371_CR14","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jacbts.2020.11.012","volume":"6","author":"TE Sharp 3rd","year":"2021","unstructured":"Sharp TE 3rd, Scarborough AL, Li Z, Polhemus DJ, Hidalgo HA, Schumacher JD et al (2021) Novel G\u00f6ttingen miniswine model of heart failure with preserved ejection fraction integrating multiple comorbidities. JACC Basic Transl Sci 6(2):154\u2013170","journal-title":"JACC Basic Transl Sci"},{"issue":"1","key":"10371_CR15","first-page":"92","volume":"7","author":"CJ Charles","year":"2020","unstructured":"Charles CJ, Lee P, Li RR, Yeung T, Ibraham Mazlan SM, Tay ZW et al (2020) A porcine model of heart failure with preserved ejection fraction: magnetic resonance imaging and metabolic energetics. ESC Heart Fail 7(1):92\u2013102","journal-title":"ESC Heart Fail"},{"key":"10371_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.879214","volume":"13","author":"H Li","year":"2022","unstructured":"Li H, Xia YY, Xia CL, Li Z, Shi Y, Li XB et al (2022) Mimicking metabolic disturbance in establishing animal models of heart failure with preserved ejection fraction. Front Physiol 13:879214","journal-title":"Front Physiol"},{"issue":"8","key":"10371_CR17","first-page":"844","volume":"7","author":"WB van Ham","year":"2022","unstructured":"van Ham WB, Kessler EL, Oerlemans MI, Handoko ML, Sluijter JP, van Veen TA, den Ruijter HM, de Jager SC (2022) Clinical phenotypes of heart failure with preserved ejection fraction to select preclinical animal models. Basic Transl Sci 7(8):844\u2013857","journal-title":"Basic Transl Sci"},{"issue":"3","key":"10371_CR18","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jacbts.2019.02.004","volume":"4","author":"TD Olver","year":"2019","unstructured":"Olver TD, Edwards JC, Jurrissen TJ, Veteto AB, Jones JL, Gao C et al (2019) Western diet-fed, aortic-banded Ossabaw swine: a preclinical model of cardio-metabolic heart failure. JACC Basic Transl Sci 4(3):404\u2013421","journal-title":"JACC Basic Transl Sci"},{"issue":"8","key":"10371_CR19","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.jacbts.2020.04.011","volume":"5","author":"KAS Silva","year":"2020","unstructured":"Silva KAS, Emter CA (2020) Large animal models of heart failure: a translational bridge to clinical success. JACC Basic Transl Sci 5(8):840\u2013856","journal-title":"JACC Basic Transl Sci"},{"issue":"1","key":"10371_CR20","doi-asserted-by":"publisher","first-page":"e002477","DOI":"10.1161\/JAHA.115.002477","volume":"5","author":"R Samson","year":"2016","unstructured":"Samson R, Jaiswal A, Ennezat PV, Cassidy M, Le Jemtel TH (2016) Clinical phenotypes in heart failure with preserved ejection fraction. J Am Heart Assoc 5(1):e002477","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10371_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1161\/01.RES.38.3.172","volume":"38","author":"S Sasayama","year":"1976","unstructured":"Sasayama S, Ross J Jr, Franklin D, Bloor CM, Bishop S, Dilley RB (1976) Adaptations of the left ventricle to chronic pressure overload. Circ Res 38(3):172\u2013178","journal-title":"Circ Res"},{"issue":"6","key":"10371_CR22","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1161\/01.CIR.95.6.1601","volume":"95","author":"M Koide","year":"1997","unstructured":"Koide M, Nagatsu M, Zile MR, Hamawaki M, Swindle MM, Keech G et al (1997) Premorbid determinants of left ventricular dysfunction in a novel model of gradually induced pressure overload in the adult canine. Circulation 95(6):1601\u20131610","journal-title":"Circulation"},{"issue":"3 Pt 2","key":"10371_CR23","first-page":"H983","volume":"264","author":"AM Fujii","year":"1993","unstructured":"Fujii AM, Aoyagi T, Flanagan MF, Takahashi T, Bennett-Guerrero E, Colan SD et al (1993) Response of the hypertrophied left ventricle to tachycardia: importance of maturation. Am J Physiol 264(3 Pt 2):H983\u2013H993","journal-title":"Am J Physiol"},{"issue":"11","key":"10371_CR24","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1161\/01.CIR.103.11.1570","volume":"103","author":"Y Ye","year":"2001","unstructured":"Ye Y, Gong G, Ochiai K, Liu J, Zhang J (2001) High-energy phosphate metabolism and creatine kinase in failing hearts: a new porcine model. Circulation 103(11):1570\u20131576","journal-title":"Circulation"},{"issue":"3","key":"10371_CR25","doi-asserted-by":"publisher","first-page":"H1062","DOI":"10.1152\/ajpheart.00998.2010","volume":"300","author":"RJ Gelpi","year":"2011","unstructured":"Gelpi RJ, Park M, Gao S, Dhar S, Vatner DE, Vatner SF (2011) Apoptosis in severe, compensated pressure overload predominates in nonmyocytes and is related to the hypertrophy but not function. Am J Physiol Heart Circ Physiol 300(3):H1062\u2013H1068","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"10371_CR26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1161\/01.RES.0000179722.79295.d4","volume":"97","author":"LS Song","year":"2005","unstructured":"Song LS, Pi Y, Kim SJ, Yatani A, Guatimosim S, Kudej RK et al (2005) Paradoxical cellular Ca2+ signaling in severe but compensated canine left ventricular hypertrophy. Circ Res 97(5):457\u2013464","journal-title":"Circ Res"},{"issue":"4","key":"10371_CR27","first-page":"300","volume":"60","author":"ZP Neeb","year":"2010","unstructured":"Neeb ZP, Edwards JM, Alloosh M, Long X, Mokelke EA, Sturek M (2010) Metabolic syndrome and coronary artery disease in Ossabaw compared with Yucatan swine. Comp Med 60(4):300\u2013315","journal-title":"Comp Med"},{"key":"10371_CR28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/978-1-4939-8597-5_22","volume":"1816","author":"O Bikou","year":"2018","unstructured":"Bikou O, Watanabe S, Hajjar RJ, Ishikawa K (2018) A pig model of myocardial infarction: catheter-based approaches. Methods Mol Biol 1816:281\u2013294","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10371_CR29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jtcvs.2011.09.032","volume":"143","author":"WM Yarbrough","year":"2012","unstructured":"Yarbrough WM, Mukherjee R, Stroud RE, Rivers WT, Oelsen JM, Dixon JA et al (2012) Progressive induction of left ventricular pressure overload in a large animal model elicits myocardial remodeling and a unique matrix signature. J Thorac Cardiovasc Surg 143(1):215\u2013223","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"10371_CR30","doi-asserted-by":"publisher","first-page":"H1687","DOI":"10.1152\/ajpheart.00610.2011","volume":"301","author":"CA Emter","year":"2011","unstructured":"Emter CA, Tharp DL, Ivey JR, Ganjam VK, Bowles DK (2011) Low-intensity interval exercise training attenuates coronary vascular dysfunction and preserves Ca2+-sensitive K+ current in miniature swine with LV hypertrophy. Am J Physiol Heart Circ Physiol 301(4):H1687\u2013H1694","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"10371_CR31","doi-asserted-by":"publisher","first-page":"H1348","DOI":"10.1152\/ajpheart.00578.2010","volume":"299","author":"CA Emter","year":"2010","unstructured":"Emter CA, Baines CP (2010) Low-intensity aerobic interval training attenuates pathological left ventricular remodeling and mitochondrial dysfunction in aortic-banded miniature swine. Am J Physiol Heart Circ Physiol 299(5):H1348\u2013H1356","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10371_CR32","doi-asserted-by":"publisher","first-page":"16587","DOI":"10.1038\/s41598-017-15851-2","volume":"7","author":"M Wallner","year":"2017","unstructured":"Wallner M, Eaton DM, Berretta RM, Borghetti G, Wu J, Baker ST et al (2017) A feline HFpEF model with pulmonary hypertension and compromised pulmonary function. Sci Rep 7(1):16587","journal-title":"Sci Rep"},{"issue":"4","key":"10371_CR33","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1538\/expanim.21-0050","volume":"70","author":"N Zhen","year":"2021","unstructured":"Zhen N, Loo SJ, Su LP, Tao ZH, Gui F, Luo JH et al (2021) A diastolic dysfunction model in non-human primates with transverse aortic constriction. Exp Anim 70(4):498\u2013507","journal-title":"Exp Anim"},{"issue":"1","key":"10371_CR34","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12967-017-1299-0","volume":"15","author":"M Gy\u00f6ngy\u00f6si","year":"2017","unstructured":"Gy\u00f6ngy\u00f6si M, Pavo N, Lukovic D, Zlabinger K, Spannbauer A, Traxler D et al (2017) Porcine model of progressive cardiac hypertrophy and fibrosis with secondary postcapillary pulmonary hypertension. J Transl Med 15(1):202","journal-title":"J Transl Med"},{"issue":"9","key":"10371_CR35","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1161\/01.CIR.0000157183.21404.63","volume":"111","author":"VK Munagala","year":"2005","unstructured":"Munagala VK, Hart CY, Burnett JC Jr, Meyer DM, Redfield MM (2005) Ventricular structure and function in aged dogs with renal hypertension: a model of experimental diastolic heart failure. Circulation 111(9):1128\u20131135","journal-title":"Circulation"},{"issue":"3","key":"10371_CR36","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1093\/cvr\/cvs353","volume":"97","author":"N Hamdani","year":"2013","unstructured":"Hamdani N, Bishu KG, von Frieling-Salewsky M, Redfield MM, Linke WA (2013) Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction. Cardiovasc Res 97(3):464\u2013471","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10371_CR37","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.116.003612","volume":"10","author":"BA Borlaug","year":"2017","unstructured":"Borlaug BA, Carter RE, Melenovsky V, DeSimone CV, Gaba P, Killu A et al (2017) Percutaneous pericardial resection: a novel potential treatment for heart failure with preserved ejection fraction. Circ Heart Fail 10(4):e003612","journal-title":"Circ Heart Fail"},{"issue":"8","key":"10371_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220707","volume":"14","author":"W Nachar","year":"2019","unstructured":"Nachar W, Merlet N, Maafi F, Shi Y, Mihalache-Avram T, Mecteau M et al (2019) Cardiac inflammation and diastolic dysfunction in hypercholesterolemic rabbits. PLoS ONE 14(8):e0220707","journal-title":"PLoS ONE"},{"issue":"5","key":"10371_CR39","first-page":"743","volume":"34","author":"MMP van den Dorpel","year":"2018","unstructured":"van den Dorpel MMP, Heinonen I, Snelder SM, Vos HJ, Sorop O, van Domburg RT et al (2018) Early detection of left ventricular diastolic dysfunction using conventional and speckle tracking echocardiography in a large animal model of metabolic dysfunction. Int J Cardiovasc Imaging 34(5):743\u2013749","journal-title":"Int J Cardiovasc Imaging"},{"key":"10371_CR40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12872-015-0046-9","volume":"15","author":"C Qian","year":"2015","unstructured":"Qian C, Gong L, Yang Z, Chen W, Chen Y, Xu Z et al (2015) Diastolic dysfunction in spontaneous type 2 diabetes rhesus monkeys: a study using echocardiography and magnetic resonance imaging. BMC Cardiovasc Disord 15:59","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"10371_CR41","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1161\/HYPERTENSIONAHA.107.099010","volume":"51","author":"BP Shapiro","year":"2008","unstructured":"Shapiro BP, Owan TE, Mohammed S, Kruger M, Linke WA, Burnett JC Jr et al (2008) Mineralocorticoid signaling in transition to heart failure with normal ejection fraction. Hypertension 51(2):289\u2013295","journal-title":"Hypertension"},{"issue":"7","key":"10371_CR42","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/cvr\/cvy038","volume":"114","author":"O Sorop","year":"2018","unstructured":"Sorop O, Heinonen I, van Kranenburg M, van de Wouw J, de Beer VJ, Nguyen ITN et al (2018) Multiple common comorbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress, and myocardial stiffening. Cardiovasc Res 114(7):954\u2013964","journal-title":"Cardiovasc Res"},{"issue":"9","key":"10371_CR43","doi-asserted-by":"publisher","first-page":"H1407","DOI":"10.1152\/ajpheart.00542.2015","volume":"309","author":"M Schwarzl","year":"2015","unstructured":"Schwarzl M, Hamdani N, Seiler S, Alogna A, Manninger M, Reilly S et al (2015) A porcine model of hypertensive cardiomyopathy: implications for heart failure with preserved ejection fraction. Am J Physiol Heart Circ Physiol 309(9):H1407\u2013H1418","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"12","key":"10371_CR44","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1161\/CIRCULATIONAHA.119.041886","volume":"141","author":"SJ Shah","year":"2020","unstructured":"Shah SJ, Borlaug BA, Kitzman DW, McCulloch AD, Blaxall BC, Agarwal R et al (2020) Research priorities for heart failure with preserved ejection fraction: National Heart, Lung, and Blood Institute working group summary. Circulation 141(12):1001\u20131026","journal-title":"Circulation"},{"issue":"1","key":"10371_CR45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00395-021-00891-7","volume":"116","author":"J van de Wouw","year":"2021","unstructured":"van de Wouw J, Steenhorst JJ, Sorop O, van Drie RWA, Wielopolski PA, Kleinjan A et al (2021) Impaired pulmonary vasomotor control in exercising swine with multiple comorbidities. Basic Res Cardiol 116(1):51","journal-title":"Basic Res Cardiol"},{"issue":"4","key":"10371_CR46","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s10741-020-10067-5","volume":"26","author":"C Miyagi","year":"2021","unstructured":"Miyagi C, Miyamoto T, Karimov JH, Starling RC, Fukamachi K (2021) Device-based treatment options for heart failure with preserved ejection fraction. Heart Fail Rev 26(4):749\u2013762","journal-title":"Heart Fail Rev"},{"issue":"9\u201310","key":"10371_CR47","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.jacbts.2021.06.002","volume":"6","author":"L Rosalia","year":"2021","unstructured":"Rosalia L, Ozturk C, Shoar S, Fan Y, Malone G, Cheema FH et al (2021) Device-based solutions to improve cardiac physiology and hemodynamics in heart failure with preserved ejection fraction. JACC Basic Transl Sci 6(9\u201310):772\u2013795","journal-title":"JACC Basic Transl Sci"},{"issue":"5","key":"10371_CR48","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s10741-019-09787-0","volume":"24","author":"A Burlacu","year":"2019","unstructured":"Burlacu A, Simion P, Nistor I, Covic A, Tinica G (2019) Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review. Heart Fail Rev 24(5):793\u2013803","journal-title":"Heart Fail Rev"},{"issue":"9","key":"10371_CR49","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00392-020-01633-w","volume":"109","author":"J Wintrich","year":"2020","unstructured":"Wintrich J, Kindermann I, Ukena C, Selejan S, Werner C, Maack C et al (2020) Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future. Clin Res Cardiol 109(9):1079\u20131098","journal-title":"Clin Res Cardiol"},{"issue":"5","key":"10371_CR50","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.pcad.2020.04.011","volume":"63","author":"MG Del Buono","year":"2020","unstructured":"Del Buono MG, Iannaccone G, Scacciavillani R, Carbone S, Camilli M, Niccoli G et al (2020) Heart failure with preserved ejection fraction diagnosis and treatment: an updated review of the evidence. Prog Cardiovasc Dis 63(5):570\u2013584","journal-title":"Prog Cardiovasc Dis"},{"issue":"4","key":"10371_CR51","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.121.008362","volume":"15","author":"W Sun","year":"2022","unstructured":"Sun W, Zou H, Yong Y, Liu B, Zhang H, Lu J et al (2022) The RAISE trial: a novel device and first-in-man trial. Circ Heart Fail 15(4):e008362","journal-title":"Circ Heart Fail"},{"issue":"5","key":"10371_CR52","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1002\/ehf2.12935","volume":"7","author":"T Nishikawa","year":"2020","unstructured":"Nishikawa T, Saku K, Uike K, Uemura K, Sunagawa G, Tohyama T et al (2020) Prediction of haemodynamics after interatrial shunt for heart failure using the generalized circulatory equilibrium. ESC Heart Fail 7(5):3075\u20133085","journal-title":"ESC Heart Fail"},{"issue":"2","key":"10371_CR53","first-page":"307","volume":"28","author":"Y Feld","year":"2023","unstructured":"Feld Y, Reisner Y, Meyer-Brodnitz G, Hoefler R (2023) The CORolla device for energy transfer from systole to diastole: a novel treatment for heart failure with preserved ejection fraction. Heart Fail Rev 28(2):307\u2013314","journal-title":"Heart Fail Rev"},{"issue":"4","key":"10371_CR54","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11936-019-0709-4","volume":"21","author":"DN Silverman","year":"2019","unstructured":"Silverman DN, Shah SJ (2019) Treatment of heart failure with preserved ejection fraction (HFpEF): the phenotype-guided approach. Curr Treat Options Cardiovasc Med 21(4):20","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"10","key":"10371_CR55","doi-asserted-by":"publisher","first-page":"030006052096291","DOI":"10.1177\/0300060520962910","volume":"48","author":"B Ning","year":"2020","unstructured":"Ning B, Zhang F, Song X, Hao Q, Li Y, Li R et al (2020) Cardiac contractility modulation attenuates structural and electrical remodeling in a chronic heart failure rabbit model. J Int Med Res 48(10):030006052096291","journal-title":"J Int Med Res"},{"issue":"5","key":"10371_CR56","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1161\/HYPERTENSIONAHA.107.095216","volume":"50","author":"IH Zucker","year":"2007","unstructured":"Zucker IH, Hackley JF, Cornish KG, Hiser BA, Anderson NR, Kieval R et al (2007) Chronic baroreceptor activation enhances survival in dogs with pacing-induced heart failure. Hypertension 50(5):904\u2013910","journal-title":"Hypertension"},{"issue":"1","key":"10371_CR57","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.120.316366","volume":"127","author":"D Sch\u00fcttler","year":"2020","unstructured":"Sch\u00fcttler D, Bapat A, K\u00e4\u00e4b S, Lee K, Tomsits P, Clauss S et al (2020) Animal models of atrial fibrillation. Circ Res 127(1):91\u2013110","journal-title":"Circ Res"},{"issue":"Supplement 2","key":"10371_CR58","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/01.mat.0000841012.14589.50","volume":"68","author":"T Snyder","year":"2022","unstructured":"Snyder T, Cornat F, Jem N, Pruvost R, Benoit S, Monticone E et al (2022) CARD19: In vitro and in vivo testing of the pulsatile CorWave membrane LVAD. ASAIO J 68(Supplement 2):54","journal-title":"ASAIO J"},{"issue":"2","key":"10371_CR59","first-page":"287","volume":"28","author":"C Miyagi","year":"2023","unstructured":"Miyagi C, Kuban BD, Flick CR, Polakowski AR, Miyamoto T, Karimov JH, Starling RC, Fukamachi K (2023) Left atrial assist device for heart failure with preserved ejection fraction: initial results with torque control mode in diastolic heart failure model. Heart Fail Rev 28(2):287\u2013296","journal-title":"Heart Fail Rev"},{"issue":"12","key":"10371_CR60","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1161\/CIRCRESAHA.122.320257","volume":"130","author":"J Roh","year":"2022","unstructured":"Roh J, Hill JA, Singh A, Valero-Mu\u00f1oz M, Sam F (2022) Heart failure with preserved ejection fraction: heterogeneous syndrome, diverse preclinical models. Circ Res 130(12):1906\u20131925","journal-title":"Circ Res"},{"issue":"2","key":"10371_CR61","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/ejhf.1059","volume":"20","author":"AP Louren\u00e7o","year":"2018","unstructured":"Louren\u00e7o AP, Leite-Moreira AF, Balligand J-L, Bauersachs J, Dawson D, De Boer RA et al (2018) An integrative translational approach to study heart failure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology. Eur J Heart Fail 20(2):216\u2013227","journal-title":"Eur J Heart Fail"},{"key":"10371_CR62","doi-asserted-by":"publisher","first-page":"910120","DOI":"10.3389\/fcvm.2022.910120","volume":"9","author":"A Malone","year":"2022","unstructured":"Malone A, Gallagher S, Saidi J, Rizq G, O\u2019Dowd E, Vallence D, Hameed A (2022) In vitro benchtop mock circulatory loop for heart failure with preserved ejection fraction emulation. Front Cardiovasc Med 9:910120","journal-title":"Front Cardiovasc Med"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-023-10371-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-023-10371-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-023-10371-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T18:25:16Z","timestamp":1709231116000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-023-10371-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["10371"],"URL":"https:\/\/doi.org\/10.1007\/s10741-023-10371-w","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,24]]},"assertion":[{"value":"8 November 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Aamir Hameed\u00a0(CMO), Andrew Malone\u00a0(CSO) and Faisal H. Cheema (Non-Executive Director)\u00a0are associated with a Startup, an RCSI and Tissue Engineering Research Group (TERG) spinout, Pumpinheart Ltd., which is developing a novel device for HFpEF. Jim O'Neill is on the advisory board of Pumpinheart Ltd.\u00a0The rest of the authors do not have any known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}